Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Optimal evaluation of patients with prolonged, recurring, or periodic fever requires extensive review of signs and symptoms to establish the onset and cardinal features of illness, to define the exact fever pattern, and to understand the context of illness within the patient’s environment, exposures, and family history. Defining fever patterns ( Box 15.1 ) is the first essential step to prioritize the differential diagnosis and pace the investigation. A comprehensive physical examination should also target specific systems (e.g., reticuloendothelial, osteoarticular) typically affected in infectious and noninfectious diseases. In children with prolonged fever, laboratory testing should include simple screening, coupled with targeted interrogation of specific organ systems only as identified by the history, physical examination, exposures, or prioritized differential diagnosis ( Box 15.2 ). For children with periodic fever, the main goal of performing screening laboratory tests is to confirm normal organ system function, direct the clinician to a specific disorder (e.g., recurrent urinary tract infection), or support the diagnosis of a noninfectious periodic fever syndrome. In evaluating children with any fever pattern, casting a broad net of imaging studies or serologic testing for unusual infectious agents is rarely fruitful in the absence of a specific exposure history or specific clinical findings.
Prolonged fever: A single illness in which the duration of fever exceeds that expected for the clinical diagnosis (e.g., >10 days for viral upper respiratory tract infections; >3 wk for mononucleosis) or A single illness in which fever was an initial major symptom and subsequently is low grade or only a perceived problem
Fever of unknown origin: A single illness of at least 3-wk duration in which fever >38.3°C occurs on most days and the diagnosis remains uncertain after 1 week of intense evaluation
Recurrent fever: A single illness in which fever and other signs and symptoms wax and wane (sometimes in relation to discontinuation of antimicrobial therapy) or Repeated unrelated febrile infections of the same organ system (e.g., sinopulmonary, urinary tract) or Multiple illnesses occurring at irregular intervals and involving different organ systems in which fever is one variable component
Periodic fever: Recurring episodes of illness for which fever is the cardinal feature, other associated symptoms are similar and stereotypical, and the duration of episodes is days to weeks, with intervening weeks to months of complete well-being; episodes can have clockwork or irregular periodicity
Growth chart
Thorough general examination
Careful organ-specific examination
Notation of mouth ulcers, exanthems, joint abnormalities, and lymph nodes
Complete blood count with manual differential count of white blood cells a
Erythrocyte sedimentation rate and C-reactive protein
Screening serum chemistry tests (and lactate dehydrogenase and uric acid levels for prolonged fever/fever of unknown origin [FUO])
Serum quantitative immunoglobulin levels
Urinalysis
Urine culture
Chest plain radiograph (for prolonged fever/FUO)
Other imaging only as directed by examination and other screening tests
Blood culture (for prolonged fever/FUO)
Serologic testing only as directed by examination, other screening tests and exposures
Complete blood count performed during episode and wellness interval (for periodic fever)
The 3 criteria for fever of unknown origin (FUO) in Petersdorf and Beeson’s landmark study of 100 adults in 1961 were illness of >3 weeks duration, fever higher than 38.3°C (101°F) on several occasions, and an uncertain diagnosis after 1 week of study in the hospital. In the 1990s, a prospective, population-based study conducted in adults in the Netherlands used fixed epidemiologic entry criteria and a specific diagnostic protocol. , In their study, the classic definition of FUO was adjusted in that immunocompromised patients were excluded and 1 week of hospitalization was replaced with 1 week of intensive evaluation (usually including computed tomography [CT] of the abdomen) and pursuit of additional diagnostic clues without arriving at a diagnosis.
In pediatrics, studies of FUO have used various definitions, with temperature thresholds between 38.0°C (100.4°F) and 38.9°C (102°F) and durations of fever ranging from 14 to 21 days. Some required the presence of daily fever and others only on multiple occasions. Reported etiologies vary broadly depending on the cohort’s definition as FUO. For purposes of this chapter, FUO in children and adolescents is considered only after a minimum of 14 days of daily documented temperature ≥38.3°C without apparent cause after performance of repeated physical examinations and screening laboratory tests and chest radiograph.
More than half of children referred for FUO do not meet these fever and exclusion criteria. The method of temperature measurement and frequency and timing of fever are ascertained and interpreted with the use of norms for age and sex ( Fig. 15.1 ). At 18 months of age, the mean rectal temperature for boys is 37.7°C with a standard deviation (SD) of 0.38°C; a rectal temperature of 38.5°C is <2 SD above the mean. Normal body temperature fluctuates within 24 hours an average by 0.5°C in adults and as much as 1.5°C in children, with temperature typically peaking in the late afternoon or evening. , A toddler with low-grade “fever” solely in the evenings likely has a normal body temperature. Additionally, patients whose sole complaint is a temperature ≤38.3°C do not merit additional pursuit as it is unlikely that a serious etiology will not be found, even if the finding is protracted or the patient is said to normally carry a “low” temperature.
In Petersdorf and Beeson’s original publication, a high incidence of serious disease was found, with the big three categories of infections accounting for 36% of cases, neoplasms for 19%, and collagen vascular diseases for 13%; miscellaneous conditions were found in 35%, and no diagnosis was found in 7% of cases. In recent studies in adults, probably because many diagnoses are made earlier with more complex imaging, serologic, or molecular diagnostic tests, a larger proportion of the smaller cadre of patients who fulfill criteria for FUO have no identified diagnosis. In a systematic review of 3164 adults with FUO investigated since 2000 (comprising 18 series, all from outside of the US), the categories of confirmed diagnoses were significantly associated with geography, and the category of no confirmed diagnosis (23% of cases) with higher income settings. Additional skewing of categories of diagnoses occurs as more patients are evaluated and managed solely as outpatients. In a study of 84 adult patients with FUO referred to a single outpatient site in Japan, 67% of patients had no diagnosis, 95% of whom had fever resolution at follow up.
In studies of FUO in children, decreasing stringency of entry criteria correlates with increased likelihood of self-limited conditions. , , In some series performed 4–5 decades ago, when fever approached 4 weeks duration without a definable source, the rate of life-altering diagnoses such as malignancy and autoimmune or autoinflammatory disease rose to 40%. , , A systematic review published in 2011 of 18 pediatric studies involving 1638 children divided studies into those performed in developed countries (i.e., 8 studies from 3 countries, all published >1 decade ago) and developing countries (i.e., 10 studies, with 8 published since 2000). Overall, categories of diagnoses in developed and developing countries were remarkably similar: infection in 51%, autoimmune or autoinflammatory diseases in 9%, malignancy in 6%, miscellaneous noninfectious conditions in 11%, and no diagnosis in 23% of cases. Infectious causes were slightly more common in developing countries (56% vs. 42%), whereas finding no cause was more common in developed countries (31% vs. 18%). The infections diagnosed in 832 children included in the aforementioned systematic review are shown in Table 15.1 . Studies in children during the last decade include small numbers of hospitalized cases, and outpatient cases likely biased by subspecialty referral. In 2 recent series of children hospitalized for FUO at 2 different US medical centers, representations of categories shifted by age group and duration of fever. However, oncologic diagnoses were least represented overall. , Among 120 children evaluated for unexplained fever in a single outpatient pediatric infectious diseases referral site who received no definitive diagnosis or were thought to have recurrent self-limited illnesses, only 3 patients were diagnosed with a fever-related condition after 8 years of follow up. Regardless of setting of evaluation of children with FUO, finding no diagnosis has risen to represent almost one-half of cases, , which typically predicts spontaneous resolution without sequelae. , ,
Infectious Cause | Developed Countries a ( N = 275) | Developing Countries b ( N = 557) | Most Common Agents and Infections in Descending Order of Frequency |
---|---|---|---|
Bacteria | 56% | 61% | Developed: urinary tract, osteomyelitis, tuberculosis, Bartonella, septicemia (not specified), Salmonella, Brucella |
Developing: Brucella, urinary tract, Salmonella, tuberculosis, abscess (not specified), septicemia (not specified) | |||
Viruses | 15% | 3% | Developed: Epstein-Barr virus, cytomegalovirus, enterovirus |
Developing: Epstein-Barr virus, cytomegalovirus, human immunodeficiency virus | |||
Fungi | 1% | 0.2% | Developed: Blastomyces, Histoplasma |
Parasites | 2% | 14% | Developed: Leishmania |
Developing: Leishmania, Plasmodium | |||
Infectious syndrome without pathogen | 26% | 22% | Developed: viral syndrome (not specified), pneumonia, meningitis |
Developing: pneumonia, respiratory tract (not specified), infectious mononucleosis, viral syndrome (not specified) |
b Tunisia, India, Turkey, Poland, Argentina, Serbia, Georgia, and Kuwait.
Children <6 years of age are more likely to have an infectious cause of fever than older children and adolescents, who are more likely to have autoimmune and autoinflammatory disorders. Box 15.3 summarizes noninfectious causes of FUO. Leukemia and lymphoma are the most common malignancies diagnosed, and juvenile idiopathic arthritis, inflammatory bowel disorders, and systemic lupus erythematosus are the most common autoinflammatory and autoimmune disorders, but they may be variously classified. Kawasaki disease is the most common miscellaneous diagnosis in developed countries. Table 15.2 shows discriminating features of infectious and noninfectious causes of FUO. Epstein-Barr virus (EBV), Bartonella henselae, infections related to the kidney and urinary tract, and osteomyelitis (especially of spine and pelvic bones) are the most common infections identified in recent studies. , , Agents that produce granulomatous infections (i.e., Bartonella, Mycobacterium, Salmonella, Histoplasma, Brucella, and Francisella spp.) disproportionately cause FUO and frequently involve the visceral organs, reticuloendothelial system, and bone marrow. In addition, FUO also can be the manifestation of a heralding unusual infection (such as disseminated Candida, Cryptococcus , or Aspergillus infection) due to congenital immunodeficiency.
Kawasaki disease
Autoimmune diseases
Autoinflammatory disorders
Inflammatory bowel disease
Malignancy
Drugs, other medicinal and nutritional products
Munchausen syndrome by proxy
Dysautonomia
Central thermoregulatory disorder
Diabetes insipidus
Anhidrotic ectodermal dysplasia
Hyperthyroidism
Hematoma in a closed space
Pulmonary embolus
Causes of Fever | Exposure and Heightened Risk of Certain Underlying Conditions a | Features | Methods of Diagnosis |
---|---|---|---|
Infectious Causes | |||
Salmonella spp. | Exposure to endemic pathogen; immigration; turtles, chickens, ducks and other animals; foods | High spiking fever; overlooked or mild abdominal pain | Culture blood, stool; culture bone marrow (especially if antibiotic given) |
Bartonella henselae , | Exposure to kittens Risk in immunocompromised people |
Mild abdominal complaints, night sweats, weight loss, headache; lymphadenopathy usually absent; hepatic, splenic, or bone marrow granulomas | Serology; PCR; histology of tissue |
Epstein-Barr virus , | Exposure ubiquitous Risk in immunocompromised people |
Typhoidal course without classic mononucleosis symptoms or signs; malaise; pneumonia | Serology; plasma PCR |
Yersinia enterocolitica | Exposure to animals, especially pigs; pork chitterlings | Abdominal pain; hepatic or splenic granulomas or abscesses; exanthems | Culture blood, stool, biopsy specimen; serology |
Mycobacterium tuberculosis | Exposure to symptomatic adults; endemic; immigration Risk in immunocompromised people, HIV, biologic response modifying drugs |
Extrapulmonary, miliary, disseminated disease | Chest radiograph; tuberculin skin test and interferon-γ release assay; culture/PCR gastric aspirate, bone marrow, or biopsy specimen |
Nontuberculous mycobacteria | Exposure ubiquitous Risk in HIV, malignancy, cystic fibrosis |
Respiratory or gastrointestinal symptoms; mediastinal lymphadenopathy | Culture/PCR gastric aspirate, blood, stool, mediastinal or enteric biopsy specimen; tissue histology |
Plasmodium spp. , | Exposure to mosquitoes in endemic areas; rare in US from mosquitoes or blood transfusions | Persistent (early) or remitting spiking fever, splenomegaly; anemia | Wright stain blood smears, rapid malaria antigen detection test |
Brucella spp. , | Exposure to unpasteurized dairy products; farm animals; endemic areas | High spiking fever, arthralgia, hepatomegaly; elevated hepatic transaminases, Coombs-positive anemia | Serology; PCR; Culture |
Parvovirus B19 , | Exposure ubiquitous Risk in immunocompromised people; sickle cell disease |
Fever alone, arthralgia, ± rash; cytopenias | Serology; PCR |
Coxiella burnetii , | Exposure to unpasteurized dairy products; farm animals; aerosol from parturient cats | Fever persistent 5–10 days or relapsing over months; elevated levels of hepatic transaminases | Serology; PCR |
Francisella tularensis | Exposure to ticks, fleas, mites, deer flies; airborne or direct contact with animals | Ulceroglandular, typhoidal, pleuropneumonia | Serology; PCR |
Leptospira spp. | Exposure to rodents, domestic animals | Persistent or biphasic fever, aseptic meningitis; hepatitis | Serology |
Leishmania spp. | Exposure to endemic pathogen; immigration | Insidious onset (2–6 mo); hepatosplenomegaly; Coombs-positive anemia | Giemsa or Wright stain biopsy or aspirate specimen of tissue/bone marrow; culture bone; serology |
Rickettsia, Ehrlichia, Anaplasma spp. | Exposure to ticks in endemic areas | Absent or atypical rash; headache; cytopenias | Serology; PCR; Wright stain of blood or CSF (morulae of Anaplasma ) |
Babesia microti | Exposure to ticks in endemic areas; transplacental, perinatal and blood transfusion Risk in immunocompromised people, hyposplenia |
Hemolytic anemia; thrombocytopenia | Serology; PCR; Wright stain of blood smear (tetrad/Maltese cross pathognomonic) |
Neisseria meningitidis (chronic) | Sporadic | Petechial exanthema | Culture of blood |
Histoplasma capsulatum | Exposure in endemic regions; sporadic elsewhere Risk in immunocompromised people; children <2 yr |
Pneumonia, hepatosplenomegaly | Antigen detection urine and other fluids; serology |
Toxocara canis, T. cati | Exposure to dog and cat feces; pica | Hepatosplenomegaly; eosinophilia; hypergammaglobulinemia | Serology |
HIV | Exposure by sexual contact; transplacental, perinatal | Hepatosplenomegaly; mononucleosis syndrome; hypergammaglobulinemia | PCR; serology blood or saliva |
Endocarditis | Risk in congenital or acquired heart disease, central venous catheter; occasionally no underlying condition found | Malaise, weakness, splenomegaly, new heart murmur; anemia, hematuria, immune complex exanthems and glomerulonephritis; HACEK organism from blood culture; multiple and persistently positive blood culture | Blood culture; echocardiogram; consideration of uncultivatable pathogens/PCR |
Intra-abdominal or retroperitoneal abscess, retropharyngeal abscess , | Secondary to appendicitis, surgery, urinary tract infection; toddler age (for retropharyngeal); Staphylococcus aureus bloodstream infection | Localized pain or tenderness; elevated inflammatory markers; positive blood culture | Computed tomography or magnetic resonance imaging |
Pelvic or vertebral osteomyelitis | Localized pain or tenderness; elevated inflammatory markers; positive blood culture | Magnetic resonance imaging | |
Odontogenic infection | Risk from dental caries, gingivitis | Painful teeth, discomfort with chewing or biting on tongue depressor; lung abscess; submandibular or submental lymphadenopathy; swelling, tenderness of face or jaw | Dental radiography |
Kikuchi-Fujimoto disease | Endemic in Asia; found in other areas | Regional (usually cervical) or generalized lymphadenopathy; elevated inflammatory markers | Biopsy or tissue histology |
Inflammatory pseudotumor | History of nonspecific illness (presumed host-controlled infection) | Insidious; malaise, weight loss, vague abdominal pain or tenderness; anemia; elevated inflammatory markers | Abdominal computed tomography; biopsy or histology |
Noninfectious Causes | |||
Kawasaki disease (incomplete) , | Most common <8 yr of age | Asynchronous or incomplete features Kawasaki disease; elevated inflammatory markers; thrombocytosis | Clinical constellation; echocardiogram |
Systemic juvenile idiopathic arthritis , | Familial, sporadic Risk in females |
Hepatosplenomegaly, lymphadenopathy, evanescent exanthem, synovitis; anemia, elevated inflammatory markers; modestly elevated ferritin (5× normal) | Clinical constellation |
Systemic lupus erythematosus | Familial, sporadic | Malaise, weight loss; then multisystem involvement (kidneys, joints, skin) | Serum antinuclear antibody, anti–double-stranded DNA, anti–smooth muscle antibody |
Hemophagocytic lymphohistiocytosis , | Virus associated; familial; underlying rheumatologic disorder | Severe, rapidly progressive illness; hepatomegaly, lymphadenopathy, exanthem; cytopenias; extreme elevations of inflammatory markers, ferritin | Ferritin, triglyceride levels, other diagnostic criteria; macrophage phagocytosis blood cells; natural killer cell, CD8 + T-lymphocyte dysfunction |
Vasculitis syndromes | Familial, sporadic | Specific hallmarks such as renal disease, neurologic involvement, rash, uveitis, pulmonary disease | Clinical constellation; specific autoantibodies; magnetic resonance angiography; biopsy or histology |
Sarcoidosis , | Geography; race | Fatigue, weight loss, leg pain; anemia, elevated inflammatory markers; mediastinal lymphadenopathy; uveitis | Clinical constellation; FDG-PET/CT; biopsy or histology; soluble interleukin-2 receptor level |
Inflammatory bowel disease | Familial; sporadic | Linear growth failure, subtle gastrointestinal symptoms or abdominal tenderness; perirectal skin tag; iron deficiency anemia; elevated inflammatory markers | Abdominal computed tomography; MRI; barium study; endoscopy |
Lymphoreticular malignancy , | Weight loss, fatigue; nonarticular bone pain; lymphadenopathy; cytopenias; elevated lactic dehydrogenase, uric acid | Bone marrow or tissue biopsy | |
Drug hypersensitivity | Prescription or nonprescription drug exposure | Preserved sense of well-being; exanthems; eosinophilia; organ dysfunction (renal, cardiac, pulmonary) | Clinical constellation; withdrawal of drug |
Factitious fever or Munchausen syndrome by proxy | Predisposing parent-patient dynamic | Discordant temperature and vital signs; discordant parent-measured temperature and urine temperature; normal inflammatory markers | Clinical constellation; medical validation temperature |
Hypothalamic dysfunction, diabetes insipidus, dysautonomia, or absent corpus callosum , | Underlying condition; genetic syndrome; anatomic abnormality | Normal inflammatory markers; hypernatremia; no response to nonsteroidal anti-inflammatory drugs | Clinical constellation; laboratory tests and imaging |
a Healthy children and youth can become infected with any of the pathogens.
Patients with FUO are typically evaluated in phases, the pace of which is determined by the progression and severity of symptoms and laboratory test results. Screening tests are performed on all patients, with specific serologic tests and imaging studies guided by exposure histories and examination findings ( Table 15.2 ). Serology for EBV and B. henselae are typically sent early in the workup in patients with compatible clinical presentations due to the high frequency of these diagnoses. , , Bone marrow biopsy is rarely required to confirm infections. Untargeted screening for endocrine disorders is rarely fruitful.
A chest radiograph should be performed for all patients regardless of their symptoms. Abdominal ultrasound can identify organ enlargement in patients with abdominal symptoms, elevated levels of serum hepatic enzymes, or in whom hepatosplenic cat-scratch disease or paranephric infection is suspected. , CT of the sinuses is viewed as an early study for patients with symptoms of sinusitis. Chest CT may be indicated when granulomatous or embolic disease is suspected. Abdominal CT or magnetic resonance imaging (MRI) study is helpful in patients with features directing suspicion to the abdomen or sometimes when a cryptogenic malignancy is strongly suspected. In a series of 28 children with prolonged fever and abdominal symptoms or signs, an abdominal CT was abnormal in 86%. However, the yield of CT in others was low. In another study of 109 children with FUO without localization, multiple modalities, including radioisotope scans and bone marrow biopsies, rarely led to a diagnosis. The interpretation of imaging studies as “definitely normal” is unusual, which often leads to additional studies, diverting the focus from the correct diagnosis.
18 F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)/CT performed in the diagnosis of both infectious and noninfectious etiologies of FUO in adults is comparable with other molecular imaging techniques and radiolabeled leukocyte scans. American and European nuclear medicine societies have included FUO among indications for PET/CT. Inflammatory cells have high avidity for 18 F-fluoro-2-deoxy-D-glucose (18F-FDG) and thus FDG-PET/CT can help detect and differentiate infection, malignancy, and inflammatory conditions. Performing FDG-PET or FDG-PET/CT has been reported cumulatively in approximately 200 European children with FUO, with diagnosis results in approximately 50%. , In the most recent study among children in the Netherlands, FDG-PET/CT identified a cause of fever (true positive) in 48% (most commonly endocarditis, systemic-onset juvenile idiopathic arthritis, and inflammatory bowel disease). Added value is purported for true negative results as well, which among FUO cases carries a favorable prognosis for resolution.
Most patients with FUO can be managed solely as outpatients with a planned interval return visit to obtain an interim history, to repeat an examination and screening tests (if persistently febrile), and to await resolution or the appearance of diagnostic clues. If there is progression of symptoms, weight loss, a new concerning symptom, or an abnormality on examination or screening tests, then the need for hospitalization, further testing, special imaging, or acquisition of tissue for diagnosis are more strongly considered.
One of the most frequent case referrals to pediatric infectious disease subspecialists for prolonged fever is an adolescent with low-grade or falsely perceived fever or one whose fever has resolved but who feels unwell and is unable to attend school and social activities. The following assessments and management represent the experience of one author (SSL). These patients require the same rigorous approach ( Box 15.4 ) as do those with true FUO. For the subspecialist to offer a definitive opinion, the family must see a thorough and thoughtful consultation. All laboratory test results, imaging studies, and biopsy slides are reviewed. Fatigue due to deconditioning (i.e., diminution of physical strength, stamina, and vitality), loss of self-esteem, fear of failure to perform at the level of previous expectations, and secondary gain may contribute to feeling of unwellness. The findings listed in Box 15.5 are expected and only elicited by a thorough evaluation of the family setting, each complaint, and a prodded recitation of a typical 24-hour period of activity and sleep. Frequently, there is a model of chronic or new serious illness or recent loss in the family. Discordance of a lengthy list of complaints in juxtaposition to normal findings of examination and laboratory tests is pivotal. The patient always should be queried privately about potential abuse and for other informative insights. Depression should be considered. Clues in depressed individuals include a feeling of persistent sadness, lack of self-worth, dislike of or wanting to hurt oneself, anger, marginalization, and a feeling of being disliked by others. Individuals with deconditioning fatigue usually do not have these feelings, but instead have increased somatic complaints and a tendency to internalize stress.
Elicit past history, setting, and specifics of onset of illness
Delineate specifics of each current symptom/sign
Elicit full review of symptoms and systems
Obtain family history targeting autoimmune, autoinflammatory, chronic disorders in family and colleagues, stress events (death, new serious diagnosis)
Perform a complete physical examination
Perform simple screening laboratory tests
Age >12 yr
Pre-illness energy, achievement, and related attention are high
Family and self-expectations are high
Acute febrile illness occurs with an onset easily dated
Acutely was unable to perform at previous level
Loses self-esteem and fears loss of others’ “love”
Fears expectations and failure if declares self to be well
Receives attention from family, coaches, teachers, and friends as victim of illness
Feels tired all the time, is increasingly sedentary, has prolonged resting but no daytime sleeping
Retires to bed at a late hour, sleeps through night with no disruption due to any complaint
Has lengthy list of complaints, which generally are vague (“dwindles”)
Has no answer to “Why did you not go to school yesterday?”
Lists some odd and startling complaints (e.g., “shooting” pains, 30-sec “blindness,” stereotypic jerks, brief “paralysis”) dispassionately
Has no weight loss and sometimes has weight gain
Is unusually engaged and cooperative with the examination
Has normal physical and neurologic examination (may have joint hypermobility)
Has normal results of screening laboratory tests
Remarkable overlaps of occurrence in higher socioeconomic populations and in adolescent females, in array of symptoms as well as positive responses to exercise therapy suggest that many patients diagnosed by infectious diseases subspecialists as deconditioned when referred to other subspecialists may be diagnosed as orthostatic intolerance, neurally mediated hypotension, postural tachycardia syndrome (POTS), fibromyalgia, or myalgic encephalomyelitis/chronic fatigue syndrome (see Chapter 200 ).
To optimize the presentation of the diagnosis of fatigue of deconditioning and its best management begins with a precise review of findings and conclusions about what the diagnosis is and is not ( Box 15.6 ). Management is outlined in Box 15.7 . Immediate return to school is essential. The primary care physician should set the tempo for incremental return, the reconditioning program, and monitoring. A personal fitness trainer may provide the patient a new therapeutic relationship, safe from fear of failure and removed from illness-enabling family dynamics. Outcome for most patients managed in this way has been excellent, with only an occasional case (possibly marked by school absence >3 months, home tutoring, or parent with chronic pain/illness condition) requiring professional therapy.
It is a disservice to diagnose “chronic fatigue syndrome” (adult cases/internet misinformation)
It is a disservice to refer to another subspecialist for targeted symptoms
It is a disservice to endorse rest-and-wait for recovery or home tutoring
Make two precise conclusions:
What the diagnosis is not (an ongoing disease)
What the diagnosis is (deconditioning)
Summarize the history (time since onset, complaints)
Confirm and conclude that there is:
Maintenance of weight (despite poor appetite)
Lack of excessive sleep (despite tiredness and malaise)
Normal physical examination (naming the organs)
Normal laboratory tests (naming the organ systems)
Lengthy time (in weeks) since onset (time in which serious conditions would become obvious)
Point out the discordance between the lengthy list of symptoms compared with normal findings on examination and test results → → SEGUE to “These facts and findings virtually exclude a cryptic infection or any serious ongoing medical condition.” “The problem is deconditioning and not ongoing disease.”
Validate symptoms as accurate (true representation of feeling)
Validate the feeling of unwellness as correct (not made up)
Prescribe:
Incremental forced return to school
Supervised exercise program
No school absence without visit to medical provider that day
Predict early associated increase in symptoms
No “grade” on performance is allowed (by self, family, school)
Validate the patient’s symptoms as accurate
Validate their concern
Validate their medical pursuit
Justify your diagnosis
Prescribe: You should
Change the focus from illness to health
Do not EVER ask “How do you feel?”
Support the back-to-school or trip-to-provider
Support the exercise program
Verbalize empathy for associated increase in symptoms
No “grade” on performance is allowed (by patient, family, school)
Set the pace for immediate, incremental return to school and activity
Determine need for family therapy or psychiatric care
When a history is carefully obtained, most children who are referred to subspecialists for recurrent fever have multiple self-limited infections. Healthy children 2–3 years of age can have up to 10 self-limited illnesses per year, and children who attend organized childcare can have more.
In the absence of respiratory tract symptoms, fever that abates repeatedly during antibiotic therapy occasionally can result from endocarditis, renal infection, central nervous system ventricular shunt infection, or pneumonia in predisposed hosts. Relapsing infections such as Borrelia recurrentis, Brucella, and malaria are unusual or rare causes of recurring fevers distinguished by their unique exposures. Autoimmune disorders and certain autoinflammatory disorders (e.g., inflammatory bowel disease, systemic juvenile idiopathic arthritis) can also manifest with recurrent fever. Fig. 15.2 shows an approach to analyzing patients with recurrent fever.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here